top of page
Latest news
Blogs, news and more...
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease
Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay...
Sep 18, 20242 min read
PlaqueTec wins MedTech Company of the Year at the Cambridge Independent Science and Technology Awards 2024
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), has...
May 20, 20241 min read
PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development
Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by...
May 14, 20242 min read
PlaqueTec closes $8 million equity financing
The financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support...
Apr 30, 20242 min read
PlaqueTec and the Babraham Institute collaborate on phenotypic screen of coronary artery blood
Collaboration to develop a bespoke cell phenotyping assay for human blood Project aims to investigate cell types present in coronary...
Jan 23, 20242 min read
Profiling plaque to guide treatment of coronary artery disease
Published in Cardiovascular News, Dr Stephen Hoole, Chief Investigator of our BIOPATTERN trial and Consultant Cardiologist at Royal...
Dec 14, 20231 min read
PlaqueTec recruits first ten patients in BIOPATTERN trial
PlaqueTec receives the UK’s MHRA approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.
Nov 29, 20233 min read
PlaqueTec presents ePoster at 14th Annual ECS Conference
What is the relationship between protein concentration at site of coronary atheroma and fibrous cap thickness?
Nov 27, 20231 min read
bottom of page